IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, off-the-shelf, immune-modulating therapeutic cancer vaccines based on its T-win ® platform, today announced two ...

Christina Farr, managing director at Manatt Health, joins Marketplace's Meghan McCarty Carino for "Tech Bytes: Week in Review ...

Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development ...

For the biotech formerly known as Eliem Therapeutics, it’s all about the climb—Climb Bio, that is. | For the biotech formerly ...

Help Register Login Login Hi, %{firstName}% Hi, %{firstName}% Games Car rental What was it like to film your new show, ...

Chinese biotech companies WuXi AppTec and WuXi Biologics, which are being targeted by a forthcoming U.S. national security ...

(Reuters) -WuXi AppTec and WuXi Biologics are planning to sell some of their operations after the Chinese biotech companies ...

Health care stocks underperformed the broader market in 2023, with many companies falling short of their profit targets, and ...

The World Vaccine Congress in Barcelona unites experts to discuss vaccine innovation, sustainability, and global preparedness in the evolving biotech landscape.

The U.S. Food and Drug Administration has approved Sanofi and Regeneron's blockbuster drug Dupixent for patients with a ...

Bob Duggan, 80, has gone from baking cookies to building robots, investing in biotech companies, and ranking among the ...

MIAMI, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term ...